Healthcare Stocks

Varex Imaging Corp <VREX.O>: Profits of 20 cents per share anticipated for fourth quarter

  • January 27, 2023 04:01 PM PST | Reuters
 Varex Imaging Corp <VREX.O>: Profits of 20 cents per share anticipated for fourth quarter

287 28 January 2023 12:01 a.m. All figures in US dollars. Varex Imaging Corp is expected to show a decrease in its fourth quarter earnings to 20 cents​ per share according to the mean Refinitiv estimate

Read More...

IRIDEX Corp <IRIX.O>: Losses of 11  cents announced for third quarter

IRIDEX Corp <IRIX.O>: Losses of 11  cents announced for third quarter

  • November 10, 2022 03:42 PM PST | Reuters

10 November 2022 11:42 p.m. ​All figures in US dollars. The loss announced by IRIDEX Corp in the third quarter were higher than the Refinitiv mean estimate of losses. The company reported losses of -

Read More...
IRIDEX Corp reports results for the quarter ended in September - Earnings Summary

IRIDEX Corp reports results for the quarter ended in September - Earnings Summary

  • November 10, 2022 03:41 PM PST | Reuters

* IRIDEX Corp reported a quarterly adjusted loss of 11 cents​​ per share for the quarter ended in September. The mean expectation of two analysts for the quarter was for a loss of 14 cents per share.

Read More...
Vincerx Pharma Inc reports results for the quarter ended in September - Earnings Summary

Vincerx Pharma Inc reports results for the quarter ended in September - Earnings Summary

  • November 10, 2022 03:39 PM PST | Reuters

* Vincerx Pharma Inc reported a quarterly adjusted loss of 80 cents​​ per share for the quarter ended in September. The mean expectation of four analysts for the quarter was for a loss of 55 cents per

Read More...
Vincerx Pharma Inc <VINC.O>: Losses of 80  cents announced for third quarter

Vincerx Pharma Inc <VINC.O>: Losses of 80  cents announced for third quarter

  • November 10, 2022 03:39 PM PST | Reuters

10 November 2022 11:39 p.m. ​All figures in US dollars. The loss announced by Vincerx Pharma Inc in the third quarter were lower than the Refinitiv mean estimate of losses. The company reported losses

Read More...
Vor Biopharma Inc reports results for the quarter ended in September - Earnings Summary

Vor Biopharma Inc reports results for the quarter ended in September - Earnings Summary

  • November 10, 2022 03:37 PM PST | Reuters

* Vor Biopharma Inc reported a quarterly adjusted loss of 63 cents​​ per share for the quarter ended in September. The mean expectation of eight analysts for the quarter was for a loss of 61 cents per

Read More...
Vor Biopharma Inc <VOR.O>: Losses of 63  cents announced for third quarter

Vor Biopharma Inc <VOR.O>: Losses of 63  cents announced for third quarter

  • November 10, 2022 03:37 PM PST | Reuters

10 November 2022 11:36 p.m. ​All figures in US dollars. The loss announced by Vor Biopharma Inc in the third quarter were lower than the Refinitiv mean estimate of losses. The company reported losses

Read More...
OpGen Inc <OPGN.O>: Losses of 30  cents announced for third quarter

OpGen Inc <OPGN.O>: Losses of 30  cents announced for third quarter

  • November 10, 2022 03:35 PM PST | Reuters

10 November 2022 11:35 p.m. ​All figures in US dollars. The loss announced by OpGen Inc in the third quarter were lower than the Refinitiv mean estimate of losses. The company reported losses of -30

Read More...
OpGen Inc reports results for the quarter ended in September - Earnings Summary

OpGen Inc reports results for the quarter ended in September - Earnings Summary

  • November 10, 2022 03:35 PM PST | Reuters

* OpGen Inc reported a quarterly adjusted loss of 30 cents​​ per share for the quarter ended in September. The mean expectation of two analysts for the quarter was for a loss of 12 cents per share. *

Read More...
RVL Pharmaceuticals PLC reports results for the quarter ended in September - Earnings Summary

RVL Pharmaceuticals PLC reports results for the quarter ended in September - Earnings Summary

  • November 10, 2022 03:33 PM PST | Reuters

* RVL Pharmaceuticals PLC reported a quarterly adjusted loss of 16 cents​​ per share for the quarter ended in September. The mean expectation of five analysts for the quarter was for a loss of 16

Read More...
RVL Pharmaceuticals PLC <RVLP.O>: Losses of 16  cents announced for third quarter

RVL Pharmaceuticals PLC <RVLP.O>: Losses of 16  cents announced for third quarter

  • November 10, 2022 03:33 PM PST | Reuters

10 November 2022 11:33 p.m. ​All figures in US dollars. The loss announced by RVL Pharmaceuticals PLC in the third quarter were on par with the Refinitiv mean estimate of losses. The company reported

Read More...

Frequently Asked Questions

Healthcare stocks are companies involved in the healthcare industry. These companies are engaged in manufacturing. Various pharmaceutical products, including medicine, medical devices, medical care through hospitals and medical centres, health insurance, etc. Despite stock market risks, healthcare stocks can provide substantial returns in the long run. The healthcare sector has been one of the top-performing sectors over the past year. The covid-19 pandemic has accelerated its growth. Some of the top healthcare stocks include Walgreens Boots Alliance Inc. (WBA), Sage Therapeutics Inc. (SAGE), Bio-Rad Laboratories Inc. (BIO), Pfizer Inc, Moderna Inc, etc.

The healthcare sector is one of the largest and most complex sectors in the US, which is comprised of various companies that engage in a wide range of healthcare-related operations. Some of the top healthcare stocks in the US are as follows: UnitedHealth Group Inc. (UNH) Johnson & Johnson (JNJ) Pfizer Inc (PFE) Abbvie Inc (ABBV) Eli Lilly and Co (LLY)

The healthcare sector is one of the centers of attraction of investors in recent days, especially considering the growth potentials of the companies. Some of the best US healthcare stocks are as follows, that maintained has maintained a steady momentum even amid the market downturn. Johnson & Johnson (JNJ) Abbvie Inc (ABBV) Eli Lilly and Co (LLY) Merck & Co Inc (MRK) Bristol-Myers Squibb Co (BMY)

AI healthcare stocks are companies that use artificial intelligence to provide tailor-made products and services to the healthcare industry. The innovation in AI healthcare companies is rapidly transforming the industry. Their help to understand and classify clinical documentation, clinical notes on patients, and insight into methods for better results.